Dysplastic lesions in ulcerative colitis: Changing paradigms

Inflammatory Bowel Diseases

Volumn 16, Issue 11, 2010, Pages 1978-1983

  Allen, Patrick B ^a   Kamm, Michael A ^a,b   De Cruz, Peter ^a   Desmond, Paul V ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cancer; chromoendoscopy; dysplasia; IBD; surgery; surveillance; UC

Indexed keywords

5 ACETAMIDOSALICYLIC ACID;

AUTOFLUORESCENCE IMAGING; COLON ADENOMA; COLON POLYP; COLON RESECTION; COLONOSCOPY; CROHN DISEASE; DISEASE SEVERITY; DYSPLASIA; DYSPLASTIC LESION; ENDOSCOPIC SURGERY; HUMAN; POLYPECTOMY; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; WHITE LIGHT ENDOSCOPY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EARLY DIAGNOSIS; HUMANS; MESALAMINE; RISK;

EID: 78249256357     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21227     Document Type: Review

References (35)

1. Crohn BB, Rosenberg H,. The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci. 1925; 170: 220-228.
2. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992; 103: 1444-1451.
3. Karlen P, Lofberg R, Brostrom O, et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 1999; 94: 1047-1052.
4. Nugent FW, Haggitt RC, Gilpin PA,. Cancer surveillance in ulcerative colitis. Gastroenterology. 1991; 100: 1241-1248.
5. Sharan R, Schoen RE,. Cancer in inflammatory bowel disease. An evidence-based analysis and guide for physicians and patients. Gastroenterol Clin North Am. 2002; 31: 237-254.
6. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001; 91: 854-862.
7. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994; 107: 934-944.
8. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998; 42: 711-714.
9. Itzkowitz SH, Present DH,. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 314-321.
10. Fogt F, Urbanski SJ, Sanders ME, et al. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Hum Pathol. 2000; 31: 288-291.
11. Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981; 80: 366-374.
12. Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004; 60: 334-339.
13. Rubin DT, Rothe JA, Hetzel JT, et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007; 65: 998-1004.
14. Eaden JA, Mayberry JF,. Colorectal cancer complicating ulcerative colitis: a review. Am J Gastroenterol. 2000; 95: 2710-2719.
15. Kiesslich R, Hoffman A, Neurath MF,. Colonoscopy, tumors, and inflammatory bowel disease new diagnostic methods. Endoscopy. 2006; 38: 5-10.
16. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy. 2005; 37: 1186-1192.
17. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004; 53: 256-260.
18. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003; 124: 880-888.
19. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008; 103: 2342-2349.
20. Kiesslich R, Burg J, Vieth M, et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology. 2004; 127: 706-713.
21. Participants in the Paris W. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003; 58: S3-S43.
22. Kudo S, Rubio CA, Teixeira CR, et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy. 2001; 33: 367-373.
23. Hurlstone DP, Cross SS, Adam I, et al. Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis. Gut. 2004; 53: 284-290.
24. van den Broek FJ, Fockens P, van Eeden S, et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut. 2008; 57: 1083-1089.
25. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007; 132: 874-882.
26. Schneider A, Stolte M,. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol. 1993; 31: 653-656.
27. Torres C, Antonioli D, Odze RD,. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol. 1998; 22: 275-284.
28. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997; 275: 1787-1790.
29. Munemitsu S, Albert I, Souza B, et al. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A. 1995; 92: 3046-3050.
30. Walsh SV, Loda M, Torres CM, et al. P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol. 1999; 23: 963-969.
31. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999; 117: 1295-1300.
32. Engelsgjerd M, Farraye FA, Odze RD,. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999; 117: 1288-1294; discussion 1488-1291.
33. Odze RD, Farraye FA, Hecht JL, et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004; 2: 534-541.
34. Hurlstone DP, Sanders DS, Atkinson R, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut. 2007; 56: 838-846.
35. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006; 130: 1030-1038.